My Integrative Self

06/02/2026

The field of heart care is changing because of new dissolvable heart stents, also known as bioresorbable vascular scaffolds.

Traditional metal stents stay inside a person's body forever.

However, these temporary scaffolds support blocked arteries for only six to twelve months while the blood vessel heals.

Because these stents are made from safe materials like magnesium or polylactide, they eventually break down into carbon dioxide and water.

The body then naturally removes these elements over two to three years.

Once the stent dissolves, the healed blood vessel can expand and contract normally again.

This is an important biological action that rigid metal stents usually block.

The main benefit of this technology is that it leaves nothing behind in the body. This greatly lowers the long-term risk of blood clots and ongoing swelling.

By helping the vessel heal naturally and reducing scar tissue, dissolvable stents give patients a better quality of life and make future medical treatments easier.

Even though early designs had problems in smaller blood vessels, current improvements are making the technology better, focusing on long-term health.

Image is for representation purpose only.

06/02/2026

Scientists are developing a powerful new probiotic designed to fight Helicobacter pylori, the dangerous bacteria strongly linked to stomach cancer, ulcers, and chronic stomach inflammation. Researchers say this engineered probiotic may help remove harmful bacteria from the digestive system while protecting healthy gut microbes at the same time. That approach could become a major breakthrough in cancer prevention and gut health research.

Helicobacter pylori infects nearly half the world’s population and is considered one of the leading risk factors for gastric cancer. Traditional antibiotic treatments can sometimes fail because the bacteria is becoming more resistant to medication. This new probiotic strategy is attracting global attention because it may offer a safer and more targeted solution without damaging beneficial bacteria inside the gut microbiome.

Experts believe future probiotic therapies could completely change how doctors prevent stomach diseases linked to bacterial infections. Early research results are already generating excitement across the medical community because stomach cancer remains one of the deadliest cancers worldwide. While more clinical testing is still needed, scientists say these findings may open the door to a new generation of precision probiotics designed to fight disease directly at its source.

06/02/2026

A new treatment strategy for melanoma patients cuts the risk of the skin cancer recurring within five years nearly in half, researchers at New York’s NYU Langone Perlmutter Cancer Center said Monday

06/01/2026

Scientists used CRISPR gene editing to remove the extra chromosome responsible for Down syndrome in human cells.

Down syndrome, also known as trisomy 21, affects approximately 1 in 700 births worldwide and has long been considered a permanent genetic condition. In a groundbreaking proof-of-concept study published in PNAS Nexus, scientists developed an allele-specific gene-editing approach using CRISPR-Cas9 to selectively cleave and eliminate the extra 21st chromosome.

Testing this technique on lab-grown cells—including induced pluripotent stem cells and skin fibroblasts derived from individuals with Down syndrome—the researchers achieved a major milestone: successfully restoring normal chromosome counts. Crucially, the treatment normalized cellular patterns and gene expression, demonstrating that the genetic imbalances behind the condition can be reversed at the cellular level.

While the scientific community is celebrating this achievement, experts emphasize that the treatment is still in its infancy and far from ready for human clinical trials. Deleting an entire chromosome in a living person carries severe risks of off-target genetic damage and unintended mutations. However, if researchers can refine the technique to make it safer and more precise, it could eventually be used to target specific cell types like neurons and glial cells, offering unprecedented avenues for early developmental or even in utero interventions. Beyond Down syndrome, this innovative technique holds transformative potential for other devastating chromosomal disorders, such as Edwards syndrome (trisomy 18) and Patau syndrome (trisomy 13), which are currently fatal for most infants.

source: Hashizume, R., Wakita, S., Sawada, H., Takebayashi, S., Kitabatake, Y., Miyagawa, Y., Hirokawa, Y. S., Imai, H., & Kurahashi, H. (2025). Trisomic rescue via allele-specific multiple chromosome cleavage using CRISPR-Cas9 in trisomy 21 cells. PNAS Nexus, 4(2).

06/01/2026

Heart Attacks And Strokes Declined After COVID-19 Vaccinations, Major Study Finds

A large-scale study involving nearly 46 million adults in England found that the incidence of heart attacks, strokes, and other common cardiovascular events was lower after COVID-19 vaccination compared to before vaccination or among those who remained unvaccinated.

Researchers analyzed health records collected during the first two years of the vaccination rollout and observed that the risk of arterial clot-related events, including heart attacks and strokes, decreased following both first and second vaccine doses. The reduction was especially noticeable after second doses of the vaccines studied.

The study also confirmed that some rare side effects—such as myocarditis after mRNA vaccines and vaccine-induced clotting disorders after adenovirus-based vaccines—can occur, but researchers emphasized that these events remain uncommon and that the overall benefits of vaccination outweigh the risks.

Scientists say the findings add to growing evidence that COVID-19 vaccination not only helps prevent severe illness but may also reduce the cardiovascular complications that can follow COVID-19 infection itself.

06/01/2026

05/27/2026

🧠💡 Scientists at Northwestern University just crossed a major milestone: they printed artificial neurons that actually communicate with living brain tissue. Using a specialized printing technique called aerosol jet printing, the team created flexible electronic neurons made from molybdenum disulfide (MoS₂) — and when placed against real mouse brain cells, the artificial ones successfully triggered neural responses. This breakthrough moves us closer to brain-machine interfaces that could restore hearing, vision, and movement in people with paralysis or neurological disease. The brain is 100,000 times more energy-efficient than today's digital computers, making these brain-inspired chips the future of AI hardware.

What are the most exciting potential uses for this kind of technology? How could it change medicine in the long run?

Disclaimer: This content is for informational and educational purposes only.

05/25/2026

NanoRevive